Use of Lidocaine During Microneedling
Topical lidocaine should be applied 30-60 minutes before microneedling procedures, with the optimal approach being a 45-60 minute application time for maximum analgesic effect, staying within maximum safe doses of 4.5 mg/kg for adults (or 7.0 mg/kg when combined with epinephrine). 1, 2
Application Method and Timing
The evidence strongly supports a specific protocol for lidocaine use during microneedling:
- Apply topical lidocaine cream to the treatment area and allow 30-60 minutes of contact time before the procedure 1
- 45-60 minutes provides superior analgesia compared to shorter application times, with research demonstrating that 45-minute application significantly improves patient comfort, tolerance, cooperation, and pain scores compared to routine 60-minute application without microneedling enhancement 2
- After application, wash hands thoroughly with soap and water 3
Enhanced Delivery Technique
A particularly effective approach involves:
- Apply topical lidocaine cream initially for 10 minutes
- Use a roller microneedle device to create microchannels in the skin
- Reapply additional lidocaine cream
- Continue topical anesthesia for an additional 35-50 minutes (total time 45-60 minutes)
This method significantly reduces pain scores (mean VAS 2.1 vs 5.9 on untreated side, p<0.001) and provides sufficient anesthesia without requiring nerve blocks or injections 4, 2. The microneedle pre-treatment enhances transdermal penetration and shortens the effective onset time while improving analgesic intensity.
Dosing Guidelines
Critical safety parameters must be strictly observed:
Adults
- Maximum 4.5 mg/kg of lidocaine without epinephrine per treatment session
- Maximum 7.0 mg/kg of lidocaine with epinephrine per treatment session 1
Children (under 12 years)
- Maximum 1.5-2.0 mg/kg without epinephrine
- Maximum 3.0-4.5 mg/kg with epinephrine 1
- Consult a physician before use in children under 12 3
Application Frequency
- Do not apply more than 3-4 times daily 3
Safety Monitoring and Toxicity Prevention
To minimize risk of local anesthetic systemic toxicity (LAST), implement these measures:
- Use the lowest effective dose for the procedure 1
- Monitor continuously for early toxicity signs: circumoral numbness, facial tingling, metallic taste, slurred speech, auditory changes, or hallucinations progressing to seizures or cardiovascular depression 1
- Maintain active communication with the patient throughout to detect early symptoms 1
Contraindications and Alternatives
True lidocaine allergy (representing only 1% of adverse reactions) requires alternative approaches 1:
- Switch to ester-type local anesthetics (cross-reaction is rare) 1
- Consider 1% diphenhydramine (onset 5 minutes vs 1 minute for lidocaine, limited efficacy) 1
- Use bacteriostatic saline (0.9% benzyl alcohol in normal saline) 1
Clinical Pearls and Pitfalls
Common pitfalls to avoid:
- Insufficient application time (<30 minutes) results in inadequate anesthesia
- Exceeding maximum weight-based dosing increases LAST risk significantly
- Failing to account for cumulative dosing in multi-stage procedures
- Not recognizing that topical lidocaine alone may be insufficient for deeper microneedling depths
Optimal approach: The combination of microneedle-enhanced delivery with 45-60 minute application time provides the best balance of efficacy, safety, and patient comfort for scalp and facial microneedling procedures 5, 2, 4. This method achieves clinical-level anesthesia with rapid onset (within 10 minutes of completion) and minimal adverse effects 6.
For scalp microneedling specifically, cold gel compresses may be considered as monotherapy when weighing advantages and disadvantages of different methods 5, though the microneedle-enhanced lidocaine approach remains superior for most facial applications.